Stoyanova, M.; Milusheva, M.; Gledacheva, V.; Todorova, M.; Kircheva, N.; Angelova, S.; Stefanova, I.; Pencheva, M.; Vasileva, B.; Hristova-Panusheva, K.;
et al. Silver Nanoparticles with Mebeverine in IBS Treatment: DFT Analysis, Spasmolytic, and Anti-Inflammatory Effects. Pharmaceutics 2025, 17, 561.
https://doi.org/10.3390/pharmaceutics17050561
AMA Style
Stoyanova M, Milusheva M, Gledacheva V, Todorova M, Kircheva N, Angelova S, Stefanova I, Pencheva M, Vasileva B, Hristova-Panusheva K,
et al. Silver Nanoparticles with Mebeverine in IBS Treatment: DFT Analysis, Spasmolytic, and Anti-Inflammatory Effects. Pharmaceutics. 2025; 17(5):561.
https://doi.org/10.3390/pharmaceutics17050561
Chicago/Turabian Style
Stoyanova, Mihaela, Miglena Milusheva, Vera Gledacheva, Mina Todorova, Nikoleta Kircheva, Silvia Angelova, Iliyana Stefanova, Mina Pencheva, Bela Vasileva, Kamelia Hristova-Panusheva,
and et al. 2025. "Silver Nanoparticles with Mebeverine in IBS Treatment: DFT Analysis, Spasmolytic, and Anti-Inflammatory Effects" Pharmaceutics 17, no. 5: 561.
https://doi.org/10.3390/pharmaceutics17050561
APA Style
Stoyanova, M., Milusheva, M., Gledacheva, V., Todorova, M., Kircheva, N., Angelova, S., Stefanova, I., Pencheva, M., Vasileva, B., Hristova-Panusheva, K., Krasteva, N., Miloshev, G., Tumbarski, Y., Georgieva, M., & Nikolova, S.
(2025). Silver Nanoparticles with Mebeverine in IBS Treatment: DFT Analysis, Spasmolytic, and Anti-Inflammatory Effects. Pharmaceutics, 17(5), 561.
https://doi.org/10.3390/pharmaceutics17050561
